Loading company…
Vivalyx develops organ preservation solutions for transplantation.
Founded in 2022 and based in Aachen, Germany, Vivalyx develops and manufactures organ preservation technology for transplantation. Its Omnisol solution is designed to support organ vitality and offers a blood-free alternative for preservation methods. In April 2024, the company raised EUR 5.4 million in seed funding co-led by TechVision Fonds and Brightlands Venture Partners, with Arve Capital and GOOSE Capital participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in